Cannabis Cultivation in Australia

Home | Canna Law Blog | Cannabis Cultivation in Australia Table of Contents Toggle Growing Cannabis in Australia Though growing cannabis for personal use remains illegal in most Australian states and territories, growing for medicinal and scientific purposes was legalized under federal law in 2016. Under federal law, cultivation includes sowing seeds, planting, growing, tending, nurturing, harvesting, grafting, dividing, or transplanting a cannabis plant. Production is the separation of cannabis and cannabis resin from the plants, and manufacturing is transforming cannabis or resin into a drug or extract. The cultivation, production, or manufacturing of cannabis for medicinal or scientific purposes requires federal government licences and permits. These are issued by the Office of Drug Control under the Narcotic Drugs Act 1967. A licence is required before a permit can be obtained. There are no limits to the number of available licences, but the overall quantities of cannabis produced in Australia must not exceed domestic requirements. The number of licensed cultivators therefore depends on the federal government's assessment of demand for medicinal cannabis in Australia. Australian Medicinal Cannabis Licence To obtain a medicinal cannabis licence in Australia, the applicant must demonstrate sufficient business experience and a sound and stable financial background. They must be of good repute and have appropriate and secure sites. Evidence that the applicant is a fit and proper person with suitable staff will be required. Details of the applicant's business associates and other associates are also needed. Thorough plans of the site must be submitted along with security details. Depending on the location of the business, additional state, territory, and local government authorisations will also be necessary. Obviously, the business owner would need a tax file number issued by the Australian Taxation Office and would need to be registered for payment of GST. The federal government application fee for an initial medicinal licence is presently A$13,560 (US$ 8,900). There is also an annual licence charge, which is presently A$27,830 (US$ 18,200). Australian Medicinal Cannabis Permits Permits can be obtained only when a licence has been granted. The applicant for a permit must explain how propagation will occur and provide particulars of the propagation source and materials. When the permit relates to cultivation, the total number of plants must be stated. The total amount of cannabis to be produced must be specified when the permit relates to production. The supply pathway must also be detailed, meaning that the applicant must demonstrate arrangements with buyers that are registered pharmacists, doctors, or scientists. A risk management plan is required, and the permit holder must be prepared to report quarterly to the Office of Drug Control. The federal government application fees for initial permits range from A$8,000 to A$12,100 (US$5,300 to US$7,900). Compulsory inspection fees also apply, and these currently range from A$4,840 to $A12,810 (US$3,200 to US$8,400). More on Australian Cannabis Cultivation For more on Australiana cannabis cultivation, please check out our website, or our update as to recreational use legislation from earlier this year. Check Out Our Cannabis Law Services Share Twitter Facebook LinkedIn E-mail Comment Mathew Alderson Mathew is an international transactional lawyer and corporate advisor with a focus on entertainment, technology and creative industries. Described as a “game-changing attorney” by Variety Magazine, Mathew leads our China office and media and entertainment practice from Shanghai. He represents major Hollywood studios and producers on both motion picture and television projects. Mathew’s clientele extends to tech companies, promoters and event management companies, architectural firms, universities and publishers. Harris Sliwoski Attorney Read more posts [email protected] Read More International Cannabis Law Related Posts September 25, 2026 DEA Enforcement in a Changing Cannabis Landscape: Rescheduling, Hemp, and What Comes Next September 17, 2026 The Supreme Court May Decide if Cannabis-Related Residency Requirements are Unconstitutional September 16, 2026 A $31.8 Million Cannabis-Related Verdict That a Federal Court Wouldn’t Enforce September 15, 2026 Jason Adelstone Moderates Federal Cannabis Policy Discussion at IgniteIt Denver September 11, 2026 Medical Marijuana in Schedule III Survives Its First Major Challenge September 10, 2026 How to Acquire a Colorado Cannabis License September 4, 2026 The Intoxicating Hemp Products Ban Was Delayed a Month. Now What? August 31, 2026 Is the Global Shift to the Right Threatening International Cannabis Reforms? August 28, 2026 Oregon Cannabis Roundup: Fall 2026 August 26, 2026 Five Bills Every California Cannabis Operator Needs to Track in 2026 August 14, 2026 California Cannabis Contracts After Rescheduling: Why Your Contracts Need a Second Look August 4, 2026 DCC License Conversions After Rescheduling: How and When to Split A/M Licenses in California August 3, 2026 The Contradictions of Cannabis Law: From the United States to International Treaties July 28, 2026 What California Operators Must Do After Rescheduling: DEA Registration, License Restructuring, and 280E July 24, 2026 Medical Marijuana Schedule III Litigation: The D.C. Circuit's First Major Test Leave a comment Cancel reply